DSGN Next Earnings Date Notes

— Design Therapeutics (NASDAQ: DSGN) is a clinical-stage biotechnology company focused on developing small-molecule GeneTAC™ (Gene Targeting Chimera) therapeutics to address serious degenerative genetic diseases. The company's lead program targets Friedreich ataxia, a rare neurological disorder, while its pipeline includes drug candidates for other triplet repeat expansion disorders such as myotonic dystrophy and cystic fibrosis. As an investor preparing for the next DSGN earnings call, the most relevant business metrics to watch are R&D expenses – reflecting continued advancement of its pipeline – cash runway & balance, which indicate its ability to fund trials and development, and progress updates on IND/clinical trial milestones, as these signal de-risking events for its drug candidates. Because DSGN is not yet generating revenue from product sales, pipeline advancement, strategic partnership announcements, and clinical data readouts are the main drivers of long-term value creation. Pay close attention to any commentary on timelines for upcoming data releases, regulatory filings, and collaborations, as these can materially impact investor sentiment and the company's outlook. The next projected earnings date for DSGN is 11/4/2026 after close (stay tuned for a confirmed earnings date once announced).

DSGN Next Earnings Date FAQ

On this page we presented the DSGN Next Earnings Date information for Design Therapeutics along with recent past earnings dates. For Q2 of 2026, DSGN reported earnings of -0.320/share, with the earnings report taking place on 8/3/2026. For Q1 of 2026, DSGN reported earnings of -0.290/share, with the earnings report taking place on 4/28/2026. For Q4 of 2025, DSGN reported earnings of -0.270/share, with the earnings report taking place on 3/9/2026. For Q3 of 2025, DSGN reported earnings of -0.300/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, DSGN reported earnings of -0.340/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for DSGN is 11/4/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Design Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Design Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Design Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next DSGN earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up DSGN's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the DSGN next earnings date.